(Q32945672)

Morten Lundh

3

0 references

Nils Billestrup

Nils Billestrup

17

0 references

Lorenzo Piemonti

Lorenzo Piemonti

10

0 references

Christopher T. Workman

Christopher T Workman

9

0 references

Thomas Mandrup-Poulsen

Thomas Mandrup-Poulsen

21

0 references

Susanne Mandrup

Susanne Mandrup

7

0 references

Chantal Mathieu

20

Chantal Mathieu

0 references

Charles A. Dinarello

19

Charles A Dinarello

0 references

author name string

Dan Ploug Christensen

1

0 references

Conny Gysemans

2

0 references

Mattias Salling Dahllöf

4

0 references

Nikolai Birkbak

8

0 references

Lykke Blaabjerg

11

0 references

Valmen Monzani

12

0 references

Gianluca Fossati

13

0 references

Paolo Mascagni

14

0 references

Steven Paraskevas

15

0 references

Reid A Aikin

16

0 references

Lars Groth Grunnet

Proceedings of the National Academy of Sciences of the United States of America

18

0 references

language of work or name

English

0 references

publication date

21 January 2014

0 references

published in

0 references

volume

111

0 references

issue

3

0 references

page(s)

1055-9

0 references

cites work

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Pharmacokinetics, safety and inducible cytokine responses during a phase 1 trial of the oral histone deacetylase inhibitor ITF2357 (givinostat).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Bad news for beta-cell apoptosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Cytokines and beta-cell biology: from concept to clinical translation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaB-mediated gene expression in insulin-producing INS-1E cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Interleukin-1beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903225

Deacetylase inhibition promotes the generation and function of regulatory T cells.

21 June 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1320850111

The binding modes and binding affinities of artemisinin derivatives with Plasmodium falciparum Ca2+-ATPase (PfATP6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1320850111

Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1320850111

SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1320850111

Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1320850111

Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24395784

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24395784

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24395784